Disease management
The AI tech can spot signs of pancreatic cancer from non-contrast CT images.
The round comes nearly a year after the company announced it had raised $45 million in Series C financing.
Withings announced its B2B division, which included its first remote patient monitoring offering, in 2019.
Its fresh funds will support its product development and international expansion efforts.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
Its web-based platform also guides patients to access appropriate medical care.
The offering includes treatment and screening for prediabetes and Type 2 diabetes.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
However, researchers found that participants' tendencies toward anxiety or pain catastrophizing affected which intervention worked better.
Also, Intuitive India releases its mobile app for surgeons using the da Vinci RAS system.